Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”

Saved in:
Bibliographic Details
Main Authors: Yaser Soleimani, Seyedehhoda Khatibmasjedi, Seyed Alireza Javadinia, Sara Shenavaei Zare, Reza Chaman
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Future Science OA
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20565623.2025.2527486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849426256056025088
author Yaser Soleimani
Seyedehhoda Khatibmasjedi
Seyed Alireza Javadinia
Sara Shenavaei Zare
Reza Chaman
author_facet Yaser Soleimani
Seyedehhoda Khatibmasjedi
Seyed Alireza Javadinia
Sara Shenavaei Zare
Reza Chaman
author_sort Yaser Soleimani
collection DOAJ
format Article
id doaj-art-067d1bfbf78e463cb5cf285fac11b024
institution Kabale University
issn 2056-5623
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Future Science OA
spelling doaj-art-067d1bfbf78e463cb5cf285fac11b0242025-08-20T03:29:31ZengTaylor & Francis GroupFuture Science OA2056-56232025-12-0111110.1080/20565623.2025.2527486Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”Yaser Soleimani0Seyedehhoda Khatibmasjedi1Seyed Alireza Javadinia2Sara Shenavaei Zare3Reza Chaman4Medical School, Shahid Beheshti University of Medical Sciences, Tehran, IranPalliative care department, Case Western Reserve University, University Hospitals, Seidman Cancer Center, Cleveland, Ohio, USANon-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, IranCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, IranNon-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iranhttps://www.tandfonline.com/doi/10.1080/20565623.2025.2527486Esophageal squamous cell carcinoma (ESCC)immune checkpoint inhibitorsPD-1 inhibitorsimmune-related adverse events (irAEs)blood biomarkersneutrophil-to-lymphocyte ratio (NLR)
spellingShingle Yaser Soleimani
Seyedehhoda Khatibmasjedi
Seyed Alireza Javadinia
Sara Shenavaei Zare
Reza Chaman
Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
Future Science OA
Esophageal squamous cell carcinoma (ESCC)
immune checkpoint inhibitors
PD-1 inhibitors
immune-related adverse events (irAEs)
blood biomarkers
neutrophil-to-lymphocyte ratio (NLR)
title Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
title_full Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
title_fullStr Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
title_full_unstemmed Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
title_short Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
title_sort editorial for a predictive model for iraes in escc patients treated with pd 1 inhibitors based on blood indicators
topic Esophageal squamous cell carcinoma (ESCC)
immune checkpoint inhibitors
PD-1 inhibitors
immune-related adverse events (irAEs)
blood biomarkers
neutrophil-to-lymphocyte ratio (NLR)
url https://www.tandfonline.com/doi/10.1080/20565623.2025.2527486
work_keys_str_mv AT yasersoleimani editorialforapredictivemodelforiraesinesccpatientstreatedwithpd1inhibitorsbasedonbloodindicators
AT seyedehhodakhatibmasjedi editorialforapredictivemodelforiraesinesccpatientstreatedwithpd1inhibitorsbasedonbloodindicators
AT seyedalirezajavadinia editorialforapredictivemodelforiraesinesccpatientstreatedwithpd1inhibitorsbasedonbloodindicators
AT sarashenavaeizare editorialforapredictivemodelforiraesinesccpatientstreatedwithpd1inhibitorsbasedonbloodindicators
AT rezachaman editorialforapredictivemodelforiraesinesccpatientstreatedwithpd1inhibitorsbasedonbloodindicators